ArticleJournal of cancer survivorship : research and practice2025
Sexual symptoms in relation to curative pelvic radiotherapy in gynecological cancer patients.
Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Supportive Care for HDR Brachytherapy in Gynecological Cancer: A Single Center Experience.In vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePelvic radiotherapy (RT) causes tissue injury which could lead to vaginal problems including dryness, shortening, and tightening of the vagina, causing discomfort, and affect sexual activity. In this longitudinal, prospective study, the association between pelvic RT and sexual function were studied in primary cervical cancer and in primary uterine tumor patients.
methodsThis prospective longitudinal cohort study comprised patients with primary cervical cancer and primary uterine tumors with pelvic radiotherapy (RT). Seventy-nine cervical cancer and 43 uterine tumor patients were included from May 2014 to February 2019. Patients completed questionnaires for global health status and sexual functioning before RT start and at 3 and 12 months after RT.
resultsIn primary cervical cancer patients, the sexual activity was significantly higher in patients with pelvic RT alone compared to patients with pelvic RT + cervical brachytherapy/boost at 3 months (P = 0.007, 34.6% vs. 73.3%) and 12 months after RT (P = 0.054, 45.7% vs. 76.9%). No significant relationship was found in primary uterine tumor patients. At 12 months after RT, 52.5% of the cervix and 42.3% of the primary uterine tumor patients were sexually active. Of the cervical cancer patients, 81.8% reported symptoms as dry vagina 12 months after RT. Local estrogens did not improve the sexual activity in cervical cancer or uterine tumor patients after RT.
conclusionIn cervical cancer patients, the sexual activity was significantly higher with pelvic RT alone compared to pelvic RT + cervical brachytherapy/boost. Better medical interventions are needed to reduce the sexual symptoms. IMPLICATIONS FOR CANCER SURVIVORS: Reduced sexual activity in gynecological cancer survivors with curative pelvic RT. For the future, improved medical interventions are needed to decrease the sexual symptoms.
Indexed as
Identifiers
41134470What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.